Adrian Johnson

TLDR: Venture capital group G Squared has raised $1.1 billion for its latest fund, tapping into increasing investor demand for buying pre-existing stakes in start-ups. Startup failures in the U.S. surged by

TLDR: – G Squared, a tech-focused growth-stage venture capital firm, secured $1.1 billion for its sixth flagship fund. – The firm was advised by Goodwin Procter LLP. Tech-focused growth-stage venture capital firm

TLDR: MSMEDA is in talks with the World Bank for a second phase of venture capital financing. The overall goal is to support startups and enhance their growth opportunities. MSMEDA is currently

TLDR: Lux Capital’s Josh Wolfe is bullish on investing in AI sectors, particularly in biology and robotics. AI in biology includes companies like Recursion and EvolutionaryScale, while AI in robotics focuses on

TLDR: Palico has become the first company approved by FINRA to facilitate online LP-led secondaries deals. This approval could have significant implications on the LP-led secondaries market as companies stay private longer,

TLDR: Creatura, a climate finance firm based in Tokyo, raised $2.4 million in a Series A funding round. The funding round included investments from DBJ Capital and Mitsui Sumitomo Insurance Venture Capital.

TLDR: – Talus Bioscience, a drug discovery company, raised $11.2 million in a seed+ round led by Two Bear Capital – The funding will be used to advance therapeutic programs and expand

TLDR: Alternative asset manager Magnetar raised $235 million for an AI fund that invests in early-to-growth stage companies advancing generative AI The fund’s investor base includes leading global institutions and strategic partners,

TLDR: Indian single family office, Sattva Ventures, has seen success with venture capital investments, prompting consideration of becoming a multi-family office. This move aims to offer other families access to lucrative investments

TLDR: Ben Freeberg, a cancer survivor, launched Oncology Ventures to improve cancer care and research by focusing on startups that use data to improve care and treatment plans. The firm closed an